MedPath
FDA Approval

Olanzapine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Sandoz Inc
DUNS: 005387188
Effective Date
April 27, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Olanzapine(10 mg in 2 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Olanzapine

Product Details

NDC Product Code
0781-3159
Application Number
ANDA201588
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR
Effective Date
July 30, 2015
Code: N7U69T4SZRClass: ACTIBQuantity: 10 mg in 2 mL
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACTQuantity: 50 mg in 2 mL
TARTARIC ACIDInactive
Code: W4888I119HClass: IACTQuantity: 3.5 mg in 2 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath